Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
Huo M, Wang L, Chen Y, Shi J. · 2017
Read Tumor-selective catalytic nanomedicine by nanocatalyst delivery. by Huo M, Wang L, Chen Y, Shi J. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5572465.txt.
Description
Huo and co-authors present a research article in Nature Communications. They built a two-step catalyst that makes a toxic agent inside tumors only. Tumor cells use glucose in a distinct way and sit in a mild acid setting. The design turns those traits against the tumor.
A silica carrier holds a natural enzyme and tiny iron oxide particles. The enzyme drains glucose from tumor cells and makes hydrogen peroxide as it works. The iron particles then turn that peroxide into hydroxyl radicals. Those radicals are highly toxic and trigger tumor cell death. Normal tissue lacks the same conditions, so it should be spared. Readers get a proof of concept for selective catalytic medicine.
Catalog record
| CREATOR | Huo M, Wang L, Chen Y, Shi J. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |